NextGen Healthcare Information Systems, LLC, a fully-owned
Quality Systems, Inc.
), recently declared its receipt of the ONC HIT certification for
its latest offering. This positive piece of news should leverage
investor confidence in the stock. On a year-to-date basis, the
company's share price surged 31%.
BIO-RAD LABS -A (BIO): Free Stock Analysis
CARDINAL HEALTH (CAH): Free Stock Analysis
QUALITY SYS (QSII): Free Stock Analysis
STRAUMANN (SAUHF): Get Free Report
To read this article on Zacks.com click here.
On Sep 18, NextGen Inpatient Clinicals version 2.6 was certified
as a Complete Electronic Health Record (Complete EHR) by the
Certification Commission for Health Information Technology
(CCHIT), an ONC Authorized Certification Body (ONC-ACB). The
device is now compliant with the ONC 2014 Edition criteria, which
supports both Stage 1 and 2 Meaningful Use (MU) measures.
The EHR technology certification is an important milestone for
QSII, which renders a competitive edge to the company's product
portfolio. Compliance with MU Stage 2 was an essential benchmark
that was required to qualify eligible providers and hospitals for
funding under the American Recovery and Reinvestment Act (ARRA).
The NextGen Inpatient Clinicals is a proven solution at critical
access and community hospitals in the U.S. This comprehensive
clinical system includes computer physician order entry (CPOE),
clinical decision support, order management, advanced reporting,
clinical data repository and additional features.
Earlier, in Sep, the NextGen Healthcare Information Systems
subsidiary hit the headlines by presenting a clinical decision
support (CDS) tool that will help healthcare providers achieve
evidence-based clinical knowledge much more easily. NextGen's
client Willamette Valley Providers (WVP) has agreed to take the
program live with a commercial EHR.
Quality Systems presently has a Zacks Rank #3 (Hold). While we
remain on the sidelines regarding QSII, other medical stocks that
are worth considering include
Cardinal Health, Inc.
Bio-Rad Laboratories, Inc.
STRAUMANN HLD N AKT
). All these stocks carry a Zacks Rank #1 (Strong Buy).